World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
20054
World Ranking
18126
National Ranking
9034

Overview

Jane L. Messina is affiliated with the University of South Florida in the United States and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research is primarily concentrated in oncology, molecular biology, immunology, epidemiology, and dermatology.

The scientist's work spans several main topics including cutaneous melanoma detection and management, CAR-T cell therapy research, immunotherapy and immune responses, cancer immunotherapy and biomarkers, melanoma and MAPK pathways, cutaneous lymphoproliferative disorders research, and polyomavirus and related diseases.

Jane L. Messina's frequent collaborators include Vernon K. Sondak, Jonathan S. Zager, Amod A. Sarnaik, Ahmad A. Tarhini, and Zeynep Eroglu. These coauthors have contributed in multiple joint publications, reflecting ongoing collaborative research efforts.

Publication venues that regularly feature their work include Annals of Surgical Oncology, Cancer Research, Cancer, Annals of Oncology, and Hand Surgery & Rehabilitation.

Recent research papers authored by or associated with Jane L. Messina cover a range of topics and were published in respected journals:

  • Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases (2021, Clinical Cancer Research)
  • Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial (2022, The Lancet)
  • Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions (2023, JAMA Network Open)
  • Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients (2023, Cancer)
  • Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy (2023, Nature Cancer)

Best Publications

  • Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

    David H. Munn;Madhav D. Sharma;Deyan Hou;Babak Baban

  • Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

    Adil I. Daud;Ronald C. DeConti;Stephanie Andrews;Patricia Urbas

  • Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma

    John Albertini;C. Cruse;David Rapaport;Karen Wells

  • PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

    Kim H.T. Paraiso;Yun Xiang;Vito W. Rebecca;Ethan V. Abel

  • 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

    Jane L. Messina;David A. Fenstermacher;Steven Eschrich;Xiaotao Qu

  • Guidelines of care for the management of cutaneous squamous cell carcinoma

    Murad Alam;April Armstrong;Christian Baum;Jeremy S. Bordeaux

  • Molecular staging of malignant melanoma: correlation with clinical outcome.

    Steven C. Shivers;Xiangning Wang;Weiguo Li;Emmanuella Joseph

  • Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

    Richard Heller;Mark J. Jaroszeski;L. Frank Glass;Jane L. Messina

  • Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

    K H T Paraiso;I V Fedorenko;L P Cantini;A C Munko

  • Primary mucosal melanoma

    Ronald J. Patrick;Neil A. Fenske;Jane L. Messina

  • Interleukin-1 Receptor Antagonist Decreases Severity of Experimental Acute-Pancreatitis

    James Norman;Michael Franz;Jane Messina;Adam Riker

  • High response rate to PD-1 blockade in desmoplastic melanomas

    Zeynep Eroglu;Zeynep Eroglu;Jesse M. Zaretsky;Siwen Hu-Lieskovan;Dae Won Kim;Dae Won Kim

  • Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

    Christopher K. Bichakjian;Thomas Olencki;Sumaira Z. Aasi;Murad Alam

  • Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

    Dale Han;Jonathan S. Zager;Yu Shyr;Heidi Chen

  • Paradoxical oncogenesis—the long-term effects of BRAF inhibition in melanoma

    Geoffrey T. Gibney;Jane L. Messina;Inna V. Fedorenko;Vernon K. Sondak

  • Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.

    Carlos N. Prieto-Granada;Thomas Wiesner;Jane L. Messina;Achim A. Jungbluth

  • Age-Specific Seroprevalence of Merkel Cell Polyomavirus, BK Virus, and JC Virus

    Raphael P. Viscidi;Dana E. Rollison;Vernon K. Sondak;Barbara Silver

  • Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    Rodabe N. Amaria;Alexander M. Menzies;Alexander M. Menzies;Alexander M. Menzies;Elizabeth M. Burton;Richard A. Scolyer;Richard A. Scolyer

  • Decreased mortality of severe acute pancreatitis after proximal cytokine blockade.

    James G. Norman;Michael G. Franz;Gregory S. Fink;Jane Messina

  • Abstract 5370: PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

    Kim H. Paraiso;Vito Rebecca;Inna V. Fedorenko;Yun Xiang

Frequent Co-Authors

Vernon K. Sondak
Vernon K. Sondak University of South Florida
Douglas S. Reintgen
Douglas S. Reintgen University of South Florida
John M. Koomen
John M. Koomen University of South Florida
Anna R. Giuliano
Anna R. Giuliano University of South Florida
Massimo Tommasino
Massimo Tommasino International Agency For Research On Cancer
Adil Daud
Adil Daud University of California, San Francisco
Michael Pawlita
Michael Pawlita German Cancer Research Center
Jeffrey S. Weber
Jeffrey S. Weber New York University
Louis B. Harrison
Louis B. Harrison Moffitt Cancer Center
Alan B. Cantor
Alan B. Cantor Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn't just mean earning an MD. There are diverse online programs that support various career pathways in healthcare, each with unique benefits and entry points.

For those interested in leadership roles, healthcare administration degree programs offer training in healthcare policy, finance, and management. If you're a registered nurse aiming to advance your practice, consider adn to np programs online, which can help you become a nurse practitioner through flexible, accelerated coursework.

Nutrition and wellness careers are also in demand. With online nutrition degree programs, you can learn about dietetics, public health, and how nutrition impacts patient care. Those seeking advanced credentials in healthcare administration may opt for cahme accredited online healthcare administration programs, designed to meet quality standards and expand job prospects in executive positions.

These online degrees allow for flexible study and can open doors to rewarding opportunities in patient care, management, and beyond.

Best Scientists Citing Jane L. Messina

Trending Scientists

Recently Published Articles